Growth hormone for fertility boosts pregnancy rates in some

Clinical Trials at CHR

human growth hormone and ivf

This mean taking male hormones with growth hormones in an attempt to increase reserve and quality. When I started having ultrasounds to count follicles, my RE and I were amazed at my right ovary. Growth hormone, IGF-1, and GHRH, all increase the sensitivity of ovaries to gonadotropin stimulation and enhance follicular development. Good luck - I'm hoping I will be too! This is the 3rd time doing the antagonist protocol.

Growth Hormone May Help Diminished Ovarian Reserve Patients

HGH has been shown to help poor responders. It is suppose to improve the quality of eggs, but doesn't seem to have any impact on the number of follicles produced. The insulin-related ovarian regulatory system in health and disease. It went fairly smoothly - my RE does monitoring for various clinics so knows the process well. Cotreatment of GH combined with hMG and hCG for ovulation induction has been suggested as a way to improve follicle growth, and probably pregnancy rate, in patients with hypogonadotropic hypogonadism. Hull KL, Harvey S. They also suggested I try the human growth hormone.

However, there are some treatments being tried by various infertility specialists that may help allow these women to attempt pregnancy utilizing their own eggs. These women may have previously attempted IVF cycles which failed to result in pregnancy or were cancelled due to lack of response to medication. There are of course exceptions to this rule in that even younger women may exhibit poor response to medication despite normal testing or may have premature ovarian failure.

Many different types of stimulation protocols have been proposed for poor responders. Some use additional medications in the hope of making the ovaries more sensitive to gonadotropins.

One such medication is growth hormone. The potential benefits of combining growth hormone GH with ovarian stimulation were first reported 20 years ago. Despite this, for a variety of reasons — including limited human data, no approval by the FDA, and high cost as the drug is not covered by insurance for IVF — the treatment has failed to gain widespread use despite small studies that suggest that supplementation may be beneficial. The benefits of co-treatment of growth hormone GH supplements with ovarian stimulation were first reported 20 years ago.

The treatment has failed to gain widespread use despite studies that suggest that supplementation can be beneficial. GH is believed to help with oocyte maturation and improved egg quality. In animal studies, supplementation of GH caused an increase in Insulin-like growth factor 1 and 2 IGF-1 and IGF-2 which are both believed to play a major role in maturation. As the woman ages, her eggs do as well and aging can cause a weakness in the spindle apparatus in the egg along which chromosomes line up to divide following fertilization.

Patients who have failed to respond to ovarian stimulation while on DHEA supplementation, or had 2 eggs or fewer, will be invited to participate in the HGH trial. After careful review of literature, CHR is now investigating a new protocol to help this group of women, involving human growth hormone HGH as an adjuvant to ovarian stimulation with gonadotropins.

Human growth hormone HGH is a hormone that raises blood sugar, free fatty acids and insulin-like growth factors IGFs , which stimulates the production of proteins. HGH as a medication is best known for its use in short-stature children.

This "axis" has been associated with a number of normal physiological processes, including follicle maturation growth of eggs in the ovaries. This is an area of controversy, with conflicting results from studies trying to determine the efficacy of HGH use as an adjuvant to gonadotropins in ovarian stimulation.

After a careful review of the published data, CHR has decided that the likely reason behind the conflicting reports is the poor timing of HGH administration. Administering HGH for only a short period of time during or before stimulation, most of the published studies missed the most important time period, when the follicles are still small and are most receptive to IGF-1's proliferative effects.

At this stage, CHR investigators believe that HGH may be able to improve the quality of eggs in the follicles, and this is the hypothesis of this clinical trial. HGH clinical trail is offered to patients who are under 45 years of age, who have either failed to respond to CHR's standard ovarian stimulation while on DHEA supplementation, or who produced 2 or fewer eggs under the same protocol. If you are eligible for the study, your clinical coordinator will ask you if you want to participate in the study.

If you agree to participate, you will need to sign an informed consent, after which you will be randomized into either the study group, which receives HGH injections, or the control group, which does not receive anything no "fake" injections.

Unfortunately, human growth hormone is an expensive drug.

Iamges: human growth hormone and ivf

human growth hormone and ivf

Growth Hormone for Fertility Helps Poor Responders Many times, women labeled as poor responders end up turning to donor eggs as the only option for getting pregnant. Does growth hormone releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

human growth hormone and ivf

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.

human growth hormone and ivf

Get a Second Opinion. Or is hgh only used in ivf cases. Nil Conflict of Interest: Geoffrey Sher on Ask Dr. For more information, please contact us.